Monday 19 October 2026
Export BLSM’s income statement to Excel — free account
BlossomHill Therapeutics, Inc.
BLSM
Insiders bought in the last twelve months.
13.94
1.04
−6.94%
Follow BLSM
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | — | — | — |
+1 more TTM period Free account |
|
| 0.00% | — | — | — | ||
ROIC |
0.00% | 0.00% | 0.00% | — | |
Return on Tangible Assets |
(81.69%) | 0.00% | 0.00% | — | |
Free Cash Flow per Share |
(24.06) | 0.00 | — | 0.00 | |
Free Cash Flow |
(65.30) | — | — | — | |
Capital Expenditures |
(1.01) | — | — | — | |
| Other line items | |||||
Cash ROIC |
(36.81%) | 0.00% | 0.00% | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
0.00% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | — | — | |
Share Based Compensation of Revenue |
0.00% | — | — | — | |
Operating CF/Net income |
0.94 | — | — | — | |
Depreciation/Fixed assets |
0.29 | 0.00 | 0.00 | — | |
Capex/Depreciation |
(2.31) | — | — | — | |
Revenue per Share |
0.00 | 0.00 | — | 0.00 | |
Operating CF per Share |
(23.69) | 0.00 | — | 0.00 | |
Capex per Share |
(0.37) | 0.00 | — | 0.00 | |
Capex to Sales |
0.00 | — | — | — |
Columns are period end dates · fundamentals updated 30 Sep 2026